Persistent urinary podocyte loss following preeclampsia may reflect subclinical renal injury

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  White, Wendy M ^a   Garrett, Angelica T ^a   Craici, Iasmina M ^a   Wagner, Steven J ^a   Fitz Gibbon, Patrick D ^a   Butters, Kim A ^a   Brost, Brian C ^a   Rose, Carl H ^a   Grande, Joseph P ^a   Garovic, Vesna D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; PLACENTAL GROWTH FACTOR; PODOCIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CELL LOSS; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELLP SYNDROME; HUMAN; KIDNEY INJURY; PODOCYTE; PODOCYTURIA; PREECLAMPSIA; PREGNANCY; PROTEINURIA; PUERPERIUM; STAINING; URINALYSIS; COMPLICATION; GLOMERULUS; KIDNEY DISEASE; PATHOLOGY; URINE;

ADULT; DELIVERY, OBSTETRIC; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; PODOCYTES; PRE-ECLAMPSIA; PREGNANCY;

EID: 84899745049     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092693     Document Type: Article

References (31)

1. [No authors listed] (2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology 183: S1-S22.
2. Garovic VD, Hayman SR (2007) Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 3: 613-622. (Pubitemid 350012820)
3. Bar J, Kaplan B, Wittenberg C, Erman A, Boner G, et al. (1999) Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrology Dialysis Transplantation 14: 1129-1132. (Pubitemid 29209296)
4. Kattah AG, Asad R, Scantlebury DC, Bailey KR, Wiste HJ, et al. (2013) Hypertension in Pregnancy Is a Risk Factor for Microalbuminuria Later in Life. J Clin Hypertens (Greenwich) 15: 617-623.
5. Roest M, Banga JD, Janssen WM, Grobbee DE, Sixma JJ, et al. (2001) Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103: 3057-3061. (Pubitemid 32587851)
6. Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, et al. (2004) An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney international Supplement: S18-21.
7. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM (2008) Preeclampsia and the risk of end-stage renal disease. New England Journal of Medicine 359: 800-809.
8. Wang IK, Muo CH, Chang YC, Liang CC, Chang CT, et al. (2013) Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ : Canadian Medical Association journal =- journal de l'Association medicale canadienne 185: 207-213.
9. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, et al. (2007) Urinary podocyte excretion as a marker for preeclampsia.[see comment]. American Journal of Obstetrics and Gynecology 196: 320 e321-327.
10. Aita K, Etoh M, Hamada H, Yokoyama C, Takahashi A, et al. (2009) Acute and Transient Podocyte Loss and Proteinuria in Preeclampsia. Nephron Clinical Practice 112: c65-c70.
11. Zhao S, Gu Y, Coates G, Groome LJ, Saleem MA, et al. (2011) Altered Nephrin and Podoplanin Distribution is Associated With Disturbed Polarity Protein PARD-3 and PARD-6 Expressions in Podocytes From Preeclampsia. Reproductive Sciences: 10.1177/1933719111398145.
12. Kelder TP, Penning ME, Uh HW, Cohen D, Bloemenkamp KW, et al. (2012) Quantitative polymerase chain reaction-based analysis of podocyturia is a feasible diagnostic tool in preeclampsia. Hypertension 60: 1538-1544.
13. Wang Y, Zhao S, Loyd S, Groome LJ (2012) Increased urinary excretion of nephrin, podocalyxin, and big-h3 in women with preeclampsia. Am J Physiol Renal Physiol 302: F1084-F1089.
14. Chen G, Zhang L, Jin X, Zhou Y, Niu J, et al. (2013) Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia. Reprod Sci 20: 579-588.
15. Son GH, Kwon JY, Lee S, Park J, Kim YJ, et al. (2013) Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia. Eur J Obstet Gynecol Reprod Biol 166: 139-144.
16. Garovic VD, Craici IM, Wagner SJ, White WM, Brost BC, et al. (2013) Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 28: 1555-1561.
17. Mundel P, Shankland SJ (2002) Podocyte biology and response to injury. Journal of the American Society of Nephrology 13: 3005-3015. (Pubitemid 35386921)
18. Petermann AT, Krofft R, Blonski M, Hiromura K, Vaughn M, et al. (2003) Podocytes that detach in experimental membranous nephropathy are viable. Kidney International 64: 1222-1231. (Pubitemid 37153787)
19. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV (2003) Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 285: F40-48. (Pubitemid 36818460)
20. Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, et al. (2013) Podocyturia Predates Proteinuria and Clinical Features of Preeclampsia: Longitudinal Prospective Study. Hypertension.
21. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia.[see comment]. New England Journal of Medicine 350: 672-683. (Pubitemid 38364626)
22. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, et al. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.[see comment][erratum appears in N Engl J Med. 2006 Oct 26; 355(17): 1840]. New England Journal of Medicine 355: 992-1005. (Pubitemid 44343543)
23. Jones SL (1998) HELLP! A cry for laboratory assistance: a comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathology and Molecular Hematology 11: 147-171.
24. Jim B, Jean-Louis P, Qipo A, Garry D, Mian S, et al. (2012) Podocyturia as a Diagnostic Marker for Preeclampsia amongst High-Risk Pregnant Patients. Journal of pregnancy 2012: 984630.
25. Achenbach J, Mengel M, Tossidou I, Peters I, Park J-K, et al. (2008) Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrology Dialysis Transplantation 23: 3138-3145.
26. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, et al. (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrology Dialysis Transplantation 15: 1379-1383.
27. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, et al. (2000) Urinary podocytes for the assessment of disease activity in lupus nephritis. American Journal of the Medical Sciences 320: 112-116. (Pubitemid 30664184)
28. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, et al. (2005) Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. Journal of the American Society of Nephrology 16: 1733-1741. (Pubitemid 41716479)
29. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, et al. (2009) Urine Podocyte mRNAs Mark Progression of Renal Disease. Journal of the American Society of Nephrology 20: 1041-1052.
30. Hara M, Yanagihara T, Kihara I (2001) Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89: 342-347. (Pubitemid 34701770)
31. Heaton JM, Turner DR (1985) Persistent renal damage following pre-eclampsia: a renal biopsy study of 13 patients. J Pathol 147: 121-126. (Pubitemid 16220639)